Family Medicine Doctors in Mount Holly, NC Accepting Medicare
7 Family Medicine doctors found. Showing 1 - 7
 Michael Alson Smith, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 305 W Catawba Ave, Mount Holly, NC 28120 Phone: 704-822-6200 Fax: 704-822-1601 |
Dr. Gregory Lee Glass, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 125 W Catawba Ave, Mount Holly, NC 28120 Phone: 704-827-3014 Fax: 704-822-9114 |
John Thomas Haney, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 S Main St, Mount Holly, NC 28120 Phone: 704-587-2400 |
 Doris Catherine Pate, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 215 S Main St, Mount Holly, NC 28120 Phone: 704-587-2400 Fax: 704-587-2401 |
Miranda Rae-tsukamoto Mcgahan, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 S Main St, Mount Holly, NC 28120 Phone: 704-587-2400 |
Kendra Rene Richardson, MD Family Medicine - Sleep Medicine Medicare: Medicare Enrolled Practice Location: 215 S Main St, Ste 100, Mount Holly, NC 28120 Phone: 704-302-8555 |
Lee Alexander Beatty, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 215 S Main St, Mount Holly, NC 28120 Phone: 704-587-2400 Fax: 704-587-2401 |
News Archive
Increasing vaccination coverage in the US protects against chickenpox
Since the chickenpox vaccine became available in the U.S. in 1995, there has been a large reduction in chickenpox cases. Hospitalizations and outpatient visits for chickenpox have continued their decline after a second dose of the vaccine was recommended to improve protection against the disease, according to a new study published in the Journal of the Pediatric Infectious Diseases Society.
Gov't. shutdown creates difficult issues at NIH
The National Institutes of Health is trying to cope with the effects of the government shutdown on patients and medical research.
Phase III study of (m)RNA expression did not confer significant advantage for stage II-III lung cancer
A phase III study examining whether messenger (m)RNA expression correlated with sensitivity or resistance to chemotherapy did not confer a statistically significant advantage in overall survival for patients with resected stage II-III non-small cell lung cancer (NSCLC), according to research presented at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.
X-ray experiments demonstrate a new way to block the entry of SARS-CoV-2
As scientists across the globe race to develop a vaccine against SARS-CoV-2, the coronavirus that causes COVID-19, an international team led by Davide Corti at Vir Biotechnology and David Veesler at the University of Washington has been working around the clock on a complementary approach - identifying neutralizing antibodies that could be used as a preventative treatment or as a post-exposure therapy.
› Verified 9 days ago